Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
02/2014
02/12/2014CN103571798A Duck tembusu virus low virulent strain and application thereof
02/12/2014CN103571797A Hog cholera cell adaptive virus, hog cholera virus live vaccine prepared from hog cholera cell adaptive virus, and preparation method of hog cholera virus live vaccine
02/12/2014CN103570823A Method of preparing albumin from a solution comprising albumin and a method for inactivating viruses using caprylate in solutions containing albumin
02/12/2014CN102776179B Wheat dwarf gene tandem repeat fragment and application thereof
02/11/2014US8647638 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
02/11/2014US8647620 Chimeric factor VII molecules
02/11/2014CA2531565C Production of poxviruses with adherent or non adherent avian cell lines
02/09/2014CA2822229A1 Caprylate viral deactivation
02/06/2014WO2014022788A2 Chicken astrovirus responsible for runting stunting syndrome
02/06/2014WO2014022475A2 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
02/06/2014WO2014019990A1 Production of infectious influenza viruses
02/06/2014US20140038264 Method of producing a polypeptide or virus of interest in a continuous cell culture
02/06/2014US20140038168 Novel drug target site within gp120 of hiv
02/06/2014US20140037586 Mycovirus, plant-pathogenic fungus, plant disease control agent, method for controlling plant disease, and method for attenuating plant-pathogenic fungus
02/05/2014EP2692861A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
02/05/2014EP2691521A2 Inactivation of bacteriophages in a liquid
02/05/2014CN103562380A Recombinant alsv for preventing pathogenic viral infection of plant
02/05/2014CN103555860A SVCV (spring viraemia of carp virus) standard sample and preparation method thereof
02/05/2014CN103555766A Rabbit hemorrhagic disease virus-like particles as well as preparation method and application thereof
02/05/2014CN103555765A Transcriptional regulation tumor targeting replicative oncolytic adenovirus vector, oncolytic adenovirus carrying therapy gene and preparation method and application thereof
02/05/2014CN103555746A Recombinant porcine circovirus type 2 virus-like particle, and preparation method and application thereof
02/05/2014CN103555714A Infectious cDNA (complementary deoxyribonucleic acid) clone, construction method and application of recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein)
02/05/2014CN103555681A Method for marking enveloped virus nucleocapsid by using quantum dot
02/05/2014CN103555680A PRRSV (porcine reproductive and respiratory syndrome virus) virus-like particles with immunogenicity as well as preparation and application thereof
02/05/2014CN103555679A Enhanced green fluorescent protein recombinant H5N1 subtype influenza virus and its application
02/05/2014CN103555678A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
02/05/2014CN103555677A A method of identifying unknown adeno-associated virus (avv) sequences and a kit for the metho
02/05/2014CN103555676A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
02/05/2014CN103555675A Application of insect cell High Five in culture of antheraea pernyi nuclear polyhedrosis virus
02/05/2014CN103555674A Multiple-virus-obtaining process for proliferating porcine reproductive and respiratory syndrome virus by Marc (rhesus monkey kidney cell)-145 cell cultured by microcarriers
02/05/2014CN103555673A Method for in vitro screening in-vivo antibacterial activity bacteriophage
02/05/2014CN103555672A Coxsackie virus A16 type mouse-adapted strain and application thereof
02/05/2014CN103555671A Vibrio harveyi giant phage VP4B and application thereof
02/05/2014CN103555670A Non-tumorigenic mdck cell line for propagating viruses
02/05/2014CN103555669A 黄病毒疫苗 Flavivirus vaccines
02/05/2014CN103555653A In-vitro construction method and application of fugu rubripes ovarian cell line
02/05/2014CN103550772A Production method of pseudorabies virus vaccine
02/05/2014CN103550771A Production method of transmissible gastroenteritis virus vaccine
02/05/2014CN103550769A Production method of porcine circovirus type 2
02/05/2014CN102964432B Method for restraining phosphorylation of M1 protein of influenza virus A and applications of method
02/05/2014CN102816740B Avian influenza virus, inactivated vaccine and method for preparing same
02/05/2014CN102618504B Bivalent vaccine for hemorrhagic fever with renal syndrome and its preparation method
02/05/2014CN102327609B Production method of encephalitis B vaccine
02/05/2014CN102206663B Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
02/04/2014US8642570 ASLV vector system
02/04/2014US8642314 Optimization of expression of parvoviral rep and cap proteins in insect cells
02/04/2014US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS)
02/04/2014CA2807515C Alphavirus particles and methods for preparation
01/2014
01/30/2014WO2014018113A1 Oncolytic virus therapy for resistant tumors
01/30/2014WO2014016580A1 Transgene expression
01/30/2014WO2014015816A1 Method for removing host dna from vaccine
01/30/2014US20140030792 Therapeutic Anti-Virus VLPS
01/30/2014US20140030697 Sortase-mediated modification of viral surface proteins
01/30/2014US20140030382 Bacteriophage Treated Food Products
01/30/2014US20140030291 Influenza virus reassortment
01/30/2014US20140030290 Infectious Clones of RNA Viruses and Vaccines and Diagnostic Assays Derived Thereof
01/30/2014US20140030229 New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
01/29/2014EP2690171A1 Recombinant alsv for preventing pathogenic viral infection of plant
01/29/2014EP2688587A1 Salmonid alphavirus vaccine
01/29/2014EP2192917B1 Method for producing viral vaccines
01/29/2014CN103547669A Agent for preventing bacterial wilt disease, and method for preventing bacterial wilt disease
01/29/2014CN103547285A Immortalized avian cell lines and use thereof
01/29/2014CN103540614A Signal for packaging of influenza virus vectors
01/29/2014CN103540613A Multi plasmid system for the production of influenza virus
01/29/2014CN103540605A Capsid protein phage display particle of recombinant II porcine circovirus as well as preparation method and application thereof
01/29/2014CN103540568A Multi plasmid system for the production of influenza virus
01/29/2014CN103536913A Method for producing avian influenza virus bivalent inactivated vaccine by use of MDCK cell line
01/29/2014CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
01/29/2014CN102757941B Hepatitis A virus strain HAV-ZL2012, vaccine prepared by using same and application thereof
01/29/2014CN101563361B Influenza viruses able to infect canids, uses thereof
01/28/2014US8637653 Infectious plant viral vector and an artificial bipartite plant viral vector an infectious plant viral vector and an artificial bipartite plant viral vector
01/28/2014US8637645 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
01/28/2014US8637644 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
01/28/2014US8637313 Production of viral vectors
01/28/2014CA2666336C Use of surface display proteins to display inorganic catalysts on the surface of a yeast, bacterium or virion
01/28/2014CA2611954C Dengue serotype 2 attenuated strain
01/28/2014CA2481799C Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
01/23/2014WO2014015242A1 Measles viruses with reduced susceptibility to neutralization
01/23/2014WO2014015116A2 Novel arterivirus protein and expression mechanisms
01/23/2014WO2014014767A1 Boone cardiovirus
01/23/2014WO2014014726A1 Attenuated swine influenza vaccines and methods of making and use thereof
01/23/2014WO2013057719A3 Sample quantification by disc centrifugation
01/23/2014US20140024101 Method for increasing the replication capacity of an influenza virus in cultured cells
01/23/2014US20140024100 Measles viruses with reduced susceptibility to neutralization
01/23/2014US20140023679 Live attenuated virus vaccines for la crosse virus and other bunyaviridae
01/22/2014EP2687600A2 Pol i promoter derived from vero cells and recombinant vector containing same
01/22/2014EP2686423A1 Method of viral production in cells
01/22/2014CN103534351A Nucleic acid construct containing nucleic acid derived from genotype 1b HCV genome, HCV genome-replicating cells transfected with same, and method for producing infectious HCV particles
01/22/2014CN103525855A Method for preparing recombinant enterovirus 71 type virus-like particle
01/22/2014CN103525777A VII type Newcastle disease virus L-gene mutation attenuated vaccine strain and preparation method thereof
01/22/2014CN103525776A Oral vaccine strain for recombined rabies virus and preparation method thereof
01/22/2014CN103525775A Free receptor recombinant adenovirus group for expressing porcine reproductive and respiratory syndrome virus (PRRSV), and preparation and application thereof
01/22/2014CN103525774A Recombinant newcastle disease virus rAI4-gB vaccine strain expressing infectious laryngotracheitis virus gB protein, and construction method for the vaccine strain
01/22/2014CN103525773A Method for improving porcine reproductive and respiratory syndrome virus target cell infection titer and application of method
01/22/2014CN103525772A Strain of duck viral hepatitis virus and application thereof
01/22/2014CN103525771A Goose parvovirus and applications thereof
01/22/2014CN103525770A Application of human fetal lung fibroblast line in preparation of hepatitis A vaccines
01/22/2014CN103525766A Pig kidney cell line and application thereof
01/22/2014CN103520715A Method for producing porcine circovirus II type inactivated vaccine by utilizing WAVE bioreactor
01/21/2014US8632782 Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 267